As of Feb 11
| -0.25 / -0.71%|
The 8 analysts offering 12-month price forecasts for Amedisys Inc have a median target of 45.55, with a high estimate of 52.00 and a low estimate of 39.00. The median estimate represents a +30.52% increase from the last price of 34.90.
The current consensus among 10 polled investment analysts is to Buy stock in Amedisys Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.